NCT02498613 2025-09-25A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting122 enrolled 16 charts
NCT02769962 2025-07-28Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung CancerNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed45 enrolled 30 charts